• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡咯烷二硫代氨基甲酸金(III)衍生物作为抗肿瘤剂

Gold(III)-pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents.

作者信息

Nardon Chiara, Chiara Federica, Brustolin Leonardo, Gambalunga Alberto, Ciscato Francesco, Rasola Andrea, Trevisan Andrea, Fregona Dolores

机构信息

Department of Chemical Sciences, University of Padova Via F. Marzolo 1, 35131, Padova, Italy.

Department of Cardiac, Thoracic, and Vascular Sciences, University of Padova Via Giustiniani 2, 35128, Padova, Italy.

出版信息

ChemistryOpen. 2015 Apr;4(2):183-91. doi: 10.1002/open.201402091. Epub 2015 Feb 19.

DOI:10.1002/open.201402091
PMID:25969817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4420591/
Abstract

Transition metals offer many possibilities in developing potent chemotherapeutic agents. They are endowed with a variety of oxidation states, allowing for the selection of their coordination numbers and geometries via the choice of proper ligands, leading to the tuning of their final biological properties. We report here on the synthesis, physico-chemical characterization, and solution behavior of two gold(III) pyrrolidinedithiocarbamates (PDT), namely [Au(III)Br2(PDT)] and [Au(III)Cl2(PDT)]. We found that the bromide derivative was more effective than the chloride one in inducing cell death for several cancer cell lines. [Au(III)Br2(PDT)] elicited oxidative stress with effects on the permeability transition pore, a mitochondrial channel whose opening leads to cell death. More efficient antineoplastic strategies are required for the widespread burden that is cancer. In line with this, our results indicate that [Au(III)Br2(PDT)] is a promising antineoplastic agent that targets cellular components with crucial functions for the survival of tumor cells.

摘要

过渡金属在开发有效的化疗药物方面提供了许多可能性。它们具有多种氧化态,通过选择合适的配体可以选择其配位数和几何构型,从而调节其最终的生物学性质。我们在此报告两种金(III)吡咯烷二硫代氨基甲酸盐(PDT),即[Au(III)Br2(PDT)]和[Au(III)Cl2(PDT)]的合成、物理化学表征及溶液行为。我们发现,对于几种癌细胞系,溴化物衍生物在诱导细胞死亡方面比氯化物衍生物更有效。[Au(III)Br2(PDT)]引发氧化应激,对通透性转换孔产生影响,通透性转换孔是一种线粒体通道,其开放会导致细胞死亡。对于癌症这种广泛存在的负担,需要更有效的抗肿瘤策略。与此一致的是,我们的结果表明[Au(III)Br2(PDT)]是一种有前景的抗肿瘤药物,它靶向对肿瘤细胞存活具有关键功能的细胞成分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d243/4420591/070b5ffebbb9/open0004-0183-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d243/4420591/4f8746bb90b4/open0004-0183-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d243/4420591/1bc5f702d19e/open0004-0183-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d243/4420591/0e0e470ac71c/open0004-0183-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d243/4420591/cfd05f9e1176/open0004-0183-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d243/4420591/070b5ffebbb9/open0004-0183-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d243/4420591/4f8746bb90b4/open0004-0183-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d243/4420591/1bc5f702d19e/open0004-0183-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d243/4420591/0e0e470ac71c/open0004-0183-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d243/4420591/cfd05f9e1176/open0004-0183-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d243/4420591/070b5ffebbb9/open0004-0183-f5.jpg

相似文献

1
Gold(III)-pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents.吡咯烷二硫代氨基甲酸金(III)衍生物作为抗肿瘤剂
ChemistryOpen. 2015 Apr;4(2):183-91. doi: 10.1002/open.201402091. Epub 2015 Feb 19.
2
Organometallic Gold(III) Complexes Similar to Tetrahydroisoquinoline Induce ER-Stress-Mediated Apoptosis and Pro-Death Autophagy in A549 Cancer Cells.有机金(III)配合物类似于四氢异喹啉诱导 A549 癌细胞内质网应激介导的细胞凋亡和促死亡自噬。
J Med Chem. 2018 Apr 26;61(8):3478-3490. doi: 10.1021/acs.jmedchem.7b01694. Epub 2018 Apr 11.
3
New Variations on the Theme of Gold(III) CNN Cyclometalated Complexes as Anticancer Agents: Synthesis and Biological Characterization.新型三价金 CNN 环金属配合物作为抗癌剂的变化主题:合成与生物学特性。
Inorg Chem. 2018 Dec 3;57(23):14852-14865. doi: 10.1021/acs.inorgchem.8b02604. Epub 2018 Nov 20.
4
Gold-caged copolymer nanoparticles as multimodal synergistic photodynamic/photothermal/chemotherapy platform against lethality androgen-resistant prostate cancer.金笼共聚物纳米粒子作为多模态协同光动力/光热/化疗平台对抗致死性雄激素抵抗前列腺癌。
Biomaterials. 2019 Aug;212:73-86. doi: 10.1016/j.biomaterials.2019.05.009. Epub 2019 May 8.
5
Enhanced anti-cancer activities of a gold(III) pyrrolidinedithiocarbamato complex incorporated in a biodegradable metal-organic framework.
J Inorg Biochem. 2016 Oct;163:1-7. doi: 10.1016/j.jinorgbio.2016.06.020. Epub 2016 Jun 16.
6
Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds.金(III)配合物作为潜在的抗肿瘤剂:某些选定金(III)化合物的溶液化学和细胞毒性特性
J Med Chem. 2000 Sep 21;43(19):3541-8. doi: 10.1021/jm990492u.
7
Bioconjugation of Cyclometalated Gold(III) Lipoic Acid Fragments to Linear and Cyclic Breast Cancer Targeting Peptides.金(III)双环金属化硫辛酸片段与线性和环状乳腺癌靶向肽的生物偶联。
Mol Pharm. 2019 Nov 4;16(11):4572-4581. doi: 10.1021/acs.molpharmaceut.9b00695. Epub 2019 Oct 9.
8
Cyclometalated Gold(III) Complexes Bearing DACH Ligands.含 DACH 配体的环金属化金(III)配合物。
Inorg Chem. 2019 Jul 15;58(14):9326-9340. doi: 10.1021/acs.inorgchem.9b01031. Epub 2019 Jun 25.
9
Plasmon-Enhanced Photodynamic Cancer Therapy by Upconversion Nanoparticles Conjugated with Au Nanorods.上转换纳米粒子与金纳米棒偶联的等离子体增强光动力学癌症治疗。
ACS Appl Mater Interfaces. 2016 Nov 30;8(47):32108-32119. doi: 10.1021/acsami.6b07770. Epub 2016 Nov 18.
10
Dimethylaminopyridine derivatives of lupane triterpenoids cause mitochondrial disruption and induce the permeability transition.羽扇豆烷三萜的二甲氨基吡啶衍生物导致线粒体破坏,并诱导通透性转变。
Bioorg Med Chem. 2013 Dec 1;21(23):7239-49. doi: 10.1016/j.bmc.2013.09.066. Epub 2013 Oct 8.

引用本文的文献

1
Rational design of gold(i)-NHC complexes as anticancer agents: induction of necroptosis and paraptosis in lung adenocarcinoma.作为抗癌剂的金(I)-氮杂环卡宾配合物的合理设计:诱导肺腺癌中的坏死性凋亡和副凋亡
RSC Med Chem. 2025 Jun 19. doi: 10.1039/d5md00290g.
2
The mechanisms of action of mitochondrial targeting agents in cancer: inhibiting oxidative phosphorylation and inducing apoptosis.线粒体靶向剂在癌症中的作用机制:抑制氧化磷酸化并诱导细胞凋亡。
Front Pharmacol. 2023 Oct 25;14:1243613. doi: 10.3389/fphar.2023.1243613. eCollection 2023.
3
Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD and SIRT3.

本文引用的文献

1
Metallodrugs in medicinal inorganic chemistry.药物无机化学中的金属药物
Chem Rev. 2014 Apr 23;114(8):4540-63. doi: 10.1021/cr400460s. Epub 2014 Jan 23.
2
Beyond platinums: gold complexes as anticancer agents.超越铂类药物:金配合物作为抗癌剂。
Anticancer Res. 2014 Jan;34(1):487-92.
3
Gold(III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia.靶向抗癌治疗前沿的金(III)-二硫代氨基甲酸盐肽模拟物:针对人类乳腺肿瘤的临床前研究
神经纤维瘤病缺失细胞的肿瘤生长是由呼吸作用下降驱动的,并受到 NAD 和 SIRT3 的阻碍。
Cell Death Differ. 2022 Oct;29(10):1996-2008. doi: 10.1038/s41418-022-00991-4. Epub 2022 Apr 7.
4
Gold (III) Derivatives in Colon Cancer Treatment.用于结肠癌治疗的金(III)衍生物
Int J Mol Sci. 2022 Jan 10;23(2):724. doi: 10.3390/ijms23020724.
5
Targeting mitochondrial ion channels for cancer therapy.靶向线粒体离子通道用于癌症治疗。
Redox Biol. 2021 Jun;42:101846. doi: 10.1016/j.redox.2020.101846. Epub 2020 Dec 24.
6
Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.以泛素-蛋白酶体系统为靶点进行癌症治疗:从天然产物中发现新型抑制剂及药物再利用。
Cancer Metastasis Rev. 2017 Dec;36(4):717-736. doi: 10.1007/s10555-017-9705-x.
7
Mechanism of the Transmetalation of Organosilanes to Gold.有机硅烷与金的金属转移机理。
ChemistryOpen. 2015 Sep 10;5(1):60-4. doi: 10.1002/open.201500172. eCollection 2016 Feb.
PLoS One. 2014 Jan 2;9(1):e84248. doi: 10.1371/journal.pone.0084248. eCollection 2014.
4
Exploration of the medical periodic table: towards new targets.医学元素周期表的探索:寻求新靶点。
Chem Commun (Camb). 2013 Jun 7;49(45):5106-31. doi: 10.1039/c3cc41143e.
5
Metals and metal derivatives in medicine.医学中的金属和金属衍生物。
Mini Rev Med Chem. 2013 Feb;13(2):211-21.
6
Chemotherapeutic induction of mitochondrial oxidative stress activates GSK-3α/β and Bax, leading to permeability transition pore opening and tumor cell death.化疗诱导的线粒体氧化应激激活 GSK-3α/β 和 Bax,导致通透性转换孔开放和肿瘤细胞死亡。
Cell Death Dis. 2012 Dec 13;3(12):e444. doi: 10.1038/cddis.2012.184.
7
Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer.钌(II/III)基化合物具有令人鼓舞的抗非小细胞肺癌增殖活性。
Chemistry. 2012 Nov 5;18(45):14464-72. doi: 10.1002/chem.201202171. Epub 2012 Sep 25.
8
Noble metal-dithiocarbamates precious allies in the fight against cancer.贵金属-二硫代氨基甲酸盐:抗癌的宝贵盟友。
Mini Rev Med Chem. 2012 Oct;12(12):1216-29. doi: 10.2174/138955712802762004.
9
Coinage metal complexes against breast cancer.针对乳腺癌的金属配合物药物。
Curr Med Chem. 2012;19(23):3949-56. doi: 10.2174/092986712802002482.
10
Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics.通过靶向肽转运体实现化疗药物对肿瘤细胞的选择性递送:定制的基于金的抗癌肽模拟物。
J Med Chem. 2012 Mar 8;55(5):2212-26. doi: 10.1021/jm201480u. Epub 2012 Feb 23.